CXCL1 and breast carcinoma: Recent studies have shown that CXCL1/2 can be hyperactivated in breast cancer cell lines by chemotherapy and that blocking CXCR2 in conjunction with chemotherapeutic agents could markedly reduce lung metastases in xenograft-implanted mice [33].